Biproate CR 200 Tablet
By Biproate
Rx
10 Tablet CR in a Strip

Composition
Sodium Valproate(135mg) + Valproic Acid(58mg)

Manufacturer - Consern Pharma Limited
Consern Pharma Private Limited, Kuljive Mahajan(Mg. Director), Rural Focal Point, V.P.O. Tibba, Ludhiana - 141120, Punjab, India

Expires on or after
September, 2025

liver
Biproate CR 200 Tablet should be used cautiously in individuals with liver disease. It may be necessary to adjust the dosage of the tablet in such cases. It is important to consult with your doctor before using Biproate CR 200 Tablet if you have any liver issues. The use of this tablet is not advisable for individuals with severe liver disease or those with active liver disease. Make sure to seek guidance from your healthcare provider regarding the appropriate use of Biproate CR 200 Tablet in relation to your liver condition.

kidney
Biproate CR 200 Tablet is considered safe for use in patients with kidney disease. Available data indicates that dose adjustment may not be necessary. Consult your doctor if you have kidney issues.

alcohol
It is advised to avoid consuming alcohol while taking Biproate CR 200 Tablet.

driving
When taking Biproate CR 200 Tablet, be cautious while driving as it may lower alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Biproate CR 200 Tablet is considered unsafe during pregnancy due to definite risk to the developing baby. Use only in life-threatening situations if the benefits outweigh the risks. Consult your doctor before using.

breastfeeding
Biproate CR 200 Tablet is considered safe to use while breastfeeding. Research shows that it unlikely to pass into breastmilk in significant amounts, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹45.8
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025